Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine Injected According to a 0, 12-month Schedule
Clinical trial NCT00291876 · COMPLETED
Trial details
- NCT number
- NCT00291876
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-01-01
- Primary completion
- 2013-03-01
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.